Researcher Database | Faculty of Pharmaceutical Sciences Department of Pharmacy | Akira Takaguri |

（Last updated : 2024-12-17 21:03:39）

Visruth.jpg not found

Akira Takaguri

Department / Course Hokkaido University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy

Job Associate Professor

Academic background
2009/03 Degree Acquisition
2006/03 Degree Acquisition

Present specialized field
Pharmacology

Book and thesis
Papers	Circadian clock gene BMAL1 is involved in transforming growth factor β1 (TGF-β1)-induced fibrotic response in NRK-49F cells Cell Biology International (Co-authored) 2025/03
Papers	SR9009 attenuates TGF-β1-induced renal fibrotic responses by inhibiting the NOX4/p38 signaling pathway in NRK-49F cells European Journal of Pharmacology (Co-authored) 2025/01
Papers	Smoking-induced suppression of β-casein in milk is associated with an increase in miR-210-5p expression in mammary epithelia Biochemistry and Biophysics Reports 6 (39) (Co-authored) 2024/09
Papers	The role of tribbles homolog 2 in vascular smooth muscle cell proliferation 47 (4),pp.787-795 (Co-authored) 2023/04
Papers	Rational design and structure-activity relationship studies reveal new esterified C20-diterpenoid alkaloid analogues active against MCF-7 human breast cancer cells J Nat Med 77 (2),pp.276-283 (Co-authored) 2023/03
Display All（19）

Academic conference presentation
2014/11	A DISINTEGRIN AND METALLOPROTEASE 17, A POTENTIAL MEDIATOR OF INTERLEUKIN-1Α DEPENDENT INSULIN RESISTANCE IN L6 RAT SKELETAL MUSCLE CELLS (10th IDF-WPR and 6th AASD Scientific Meeting 2014)
2011	Constitutive stimulation of vascular smooth muscle cells by Angiotensin II derived from adenovirus encoding a furin-cleavable fusion membrane protein (The Federation of American Societies for Experimental Biology (Washington USA))
2011	Vascular Selective ADAM17 Silencing Prevented Medial Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II Infusion (High Blood Pressure Research 2011 Scientific Sessions (Orlando USA))
2011	Vascular Selective ADAM17 Silencing Prevented Medial Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II Infusion. (AHA Scientific Sessions (Orlando USA))
2010	ADAM17 is a novel therapeutic target for vascular remodeling. (Gordon Research Conference (Ventura USA))
Display All（13）